Skip to content

LifeFlow Sepsis Study

Prospective Trial Of Patient Outcomes and PALS Sepsis Guideline Adherence In Patients Fluid Resuscitated With The LifeFlow® Rapid Infuser Compared To Traditional Methods

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07191054
Enrollment
0
Registered
2025-09-24
Start date
2019-05-01
Completion date
2020-03-30
Last updated
2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

This is a prospective, comparative, blinded, randomized study to prove the safety, efficacy and ease of use of the LifeFlow® device in pediatric patients presenting to an emergency department with concern for sepsis. This study will include 600 patients, 300 will receive the LifeFlow® device to deliver intravenous fluids while another 300 patients will receive the conventional push/pull method.

Interventions

DEVICELifeFlow Rapid infuser

Use of rapid infuser to fluid resuscitate

DEVICEPush Pull

Use of Push Pull syringe technique to fluid resuscitate

Sponsors

Phoenix Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Less than 19 years old * Trigger the Best Practice Alert in triage * Treating physician elects to do the full sepsis bundle.

Exclusion criteria

* Less than 20kg in weight * Patients on diuretics for cardiac or renal conditions * Patients who cannot communicate in either English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Nursing satisfaction1 dayLikert scale of satisfaction with style of fluid administration used. From not satisfied to extremely satisfied.
Time To first bolus completion20 Minutes
Time to third bolus completion60 Minutes
Time to hospital admission24 hoursTime from presentation to the ER until admission to the hospital

Secondary

MeasureTime frameDescription
Hospital Length of StayDays
ICU daysDays
Vasoactive medication use1 dayWill measure whether vasoactive medications are used or not used
Morbidity and Mortality1 dayrate of morbidity and mortality per 100 subjects in each arm

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026